4/A
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-22-000053
Chief Accounting Officer sold 190 shares at $2.03 ($385)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Simoneit Diona Chief Accounting Officer | 2022-11-15 | Sale | −190 | $2.03 | $385 | 29,318 | D: show line 1 in the form |
| Open-market sales · 190 sh · avg $2.03 · $385 | |||||||
Loading xslF345X03/edgardoc.xml…